drugset / Trial / NCT04929626

Different Doses of Nebulized Magnesium Sulphate in Status Asthmaticus

NCT04929626

Phase 1 Completed 126 enrolled Ziauddin University
RandomizedParallel-groupDouble-blindTreatment

Summary

In this study investigators will use magnesium sulphate in the nebulized form in children between 2 and 12 years of age as an acute reliever for acute severe asthma. Aim of this study is to determine that whether adding low (250mg), intermediate (500mg), and high doses (750mg) of magnesium sulphate in the 1st hour of treatment has any difference in the improvement of clinical condition of the patient and length of hospital stay. There will be total 108 patients having 2 groups. 1st group will receive only Ventolin while 2nd group will be given Ventolin and Magnesium sulphate.

Timeline

Start
2022-01-01
Primary completion
2022-11-12
Completion
2022-11-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 250 mg Other
Subject Magnesium Sulfate Other / unclassified 500 mg Other
Subject Magnesium Sulfate Other / unclassified 750 mg Other
Comparator Salbutamol Unknown Other

Indications